A study to evaluate the efficacy of EPA enriched oral nutrition supplement (ONS) and to investigate useful biomarkers for the assessment in advanced gastrointestinal cancer patients
Phase 2
- Conditions
- Gastric cancer/Colon cancer
- Registration Number
- JPRN-UMIN000006941
- Lead Sponsor
- Department of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1. Metastatic brain disorder 2. Immune disorder 3. Cardiac disease, liver failure, renal failure, and active disease of small intestine (e.g., Crohn's disease) 4. Gastrointestinal symptoms (e.g., Intestinal obstruction, gastrointestinal bleeding, etc) 5. Allergic to the ingredient (s) 6. Uncontrollable diabetes mellitus 7. Considered inadequate for the inclusion in the study by the physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method